期刊文献+

流式细胞术在鉴别良、恶性淋巴组织增生中的价值 被引量:1

The value of flow cytometer in differentiating reactive lymphadenosis from malignant lymphoma
下载PDF
导出
摘要 目的 探讨流式细胞术测定DNA含量在鉴别反应性淋巴细胞增生与恶性淋巴瘤中的价值。方法 取石蜡包埋标本 70份 ,病理诊断为非何杰金淋巴瘤 42例 ,反应性淋巴细胞增生 2 8例。石蜡标本制成单细胞悬液 ,染色并行流式细胞术分析。结果  42例NHL中 ,3 3例为二倍体 ,9例为异倍体 ,异倍体率为 2 1.4% ,2 8例反应性淋巴细胞增生者 ,2 7例为二倍体 ,1例为异倍体 (但该病人 1个月后病理确诊为非何杰金淋巴瘤 ,并于 18个月后死于非何杰金淋巴瘤 ) ,两组异倍体率有显著性差异 (P <0 .0 5 ) ;42例非何杰金淋巴瘤S期细胞比值为 (2 7.2± 18.1) % ,2 8例反应性淋巴细胞增生S期细胞比值为 (11.9± 14 .4) % ,两组S期细胞比值有非常显著差别 (P <0 .0 1)。结论 流式细胞术测定DNA倍体数及S期细胞比值 。 Objective To evaluate the value in differentiating reactive lymphadenosis from malignant lymphoma by using flow cytometer (FCM) .Methods From 42 cases with non Hodgkin′s lymphoma(NHL) and 28 cases with reactive lymphadenosis paraffin embedded samples,single cell suspension was prepared,stained and assessed by FCM.Results Among 42 cases with NHL,33 cases (78.6%) were diploid and 9 cases (21%) aneuploid,while 27 out of 28 cases with reactive lymphadenosis were diploid and the other one was aneuploid who was diagnosed by histological examination afterwards and died of NHL in 18 months (P<0.05).S phase fraction in NHL group was (27.2±18.1)% while it was (11.9±14.4)% in reactive lymphadenosis(P<0.01).Conclusion It is helpful to use FCM to detect DNA ploidy patterns and S phase fraction in differentiating reactive lymphadenosis from malignant lymphoma.
出处 《中国肿瘤临床与康复》 2002年第2期35-35,34,共2页 Chinese Journal of Clinical Oncology and Rehabilitation
基金 福建省卫生厅科研基金资助 (编号 :960 3 9)
关键词 流式细胞术 鉴别 淋巴组织增生 反应性淋巴细胞增生 DNA含量 淋巴瘤 诊断 flow cytometer reactive lymphadenosis DNA content lymphoma
  • 相关文献

同被引文献9

  • 1纪爱芳,苏丽萍,朱镭.非霍奇金淋巴瘤流式细胞术免疫表型检测及DNA倍体分析[J].白血病.淋巴瘤,2006,15(6):422-424. 被引量:2
  • 2Kenney B, Zieske A, Rinder H,et al. DNA ploidy analysis as an adjunct for the detection of relapse in B-lineage acute lymphoblastic leukemia[J]. Leuk Lymphoma, 2008, 49(1):42
  • 3Prochazkova M, Chevret E, Mainhaguiet G, et al. Common chromosomal abnormalities in mycosis fungoides transformation [J]. Genes Chromosomes Cancer, 2007, 46(9):828
  • 4Stetler-Stevenson M, Braylan RC. Flow cytometric analysis of lymphomas and lymphoproliferative disorders [J]. Semin Hematol,2001,38(2):111
  • 5Pinto AE, Cabecadas J, Nobrega SD, et al. Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma [J]. Diagn Cytopathol,2003, 29(4):194
  • 6Jung JT, Kim DH, Kwak EK, et al. Clinical role of Bcl-2, Bax, or p53 overexpression in peripheral T-cell lymphomas[J]. Ann Hematol, 2006, 85(9):575
  • 7Naresh KN, Banamali SD, Bhatia KC, et al. Expression of P53 and bcl-2 proteins in T-cell lymphoblastic lymphoma prognostic implications[J]. Leuk Lymphoma,2002,43(2) :333
  • 8Kamata H, Mitani S, Fujiwara M,et al. Mutation of the p53 turaour suppressor gene and overexpression of its protein in 62 Japanese non-Hodgkin's lymphomas[J]. Clin Exp Med, 2007, 7(2):39
  • 9梁群英,郭瑞珍,唐文台,肖庆邦.鼻NK/T淋巴瘤中survivin、p53、bcl-2蛋白的表达与细胞凋亡[J].实用癌症杂志,2003,18(6):583-585. 被引量:5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部